ANBL1232

Utilizing Response-and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High Risk Neuroblastoma
Contact phone
517.364.5591
Principal investigator
Renuka Gera, MD
Trial Category
Childhood Cancers
Trial SubCategory
Blastoma
Webform